In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, ...

Blood tests miss early cancers and should be limited to people who decline other methods, new guidelines say.

A pioneering blood test that can detect more than 50 cancers before symptoms appear could save tens of thousands of lives a ...

An annual blood test designed to detect multiple cancers before symptoms appear is "feasible at scale" on the NHS, experts have said. The Galleri test works by identifying DNA shed by cancer cells ...

Share on Pinterest The FDA has approved a new colorectal cancer blood test by Guardant Health called Shield for Medicare coverage. Photo by Business Wire for Guardant Health The FDA has approved a ...